​Development of engineered IgM antibodies
| Year | Client | Period | Income | Expenses | Doc |
|---|---|---|---|---|---|
| 2021 | IGM BIOSCIENCES, INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | $140,000 | |
| 2021 | IGM BIOSCIENCES, INC. |
4th Quarter (Oct 1 - Dec 31) Registration |
— | — |
| Client | Filings | Total Income |
|---|---|---|
| IGM BIOSCIENCES, INC. | 14 | — |
| Name | Disclosed Prior Position |
|---|---|
| ANDREW WESLEY WOMACK |